Rare diseases
Investigational molecules
Locations
Tezepelumab Effects on TSLP Protein Induction in Adults with Severe Asthma, With and Without Chronic Rhinosinusitis
DenmarkEfficacy of Tezepelumab in Treating Bronchiolitis Obliterans Syndrome in Allogeneic Stem Cell Transplant Recipients
FranceStudy of Tezepelumab in Adults with Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD) to Reduce Disease Flare-ups
BelgiumStudy of Tezepelumab Compared to Placebo in Adults with Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)
CzechiaStudy of Tezepelumab effects on airway barrier function in patients with severe asthma, with or without chronic rhinosinusitis with nasal polyps
AustriaStudy on the Effects of Tezepelumab on Airway Inflammation in Patients with Chronic Obstructive Pulmonary Disease (COPD)
DenmarkStudy on Tezepelumab for Children Aged 5 to 11 with Severe Asthma
FranceEvaluating Gradual Interval Extension of Tezepelumab in Drug Combination for Patients with Severe Asthma
The NetherlandsComparison of dupilumab and tezepelumab for the treatment of chronic rhinosinusitis with nasal polyps.
AustriaStudy on the Effectiveness of Tezepelumab for Adults with Eosinophilic Granulomatosis with Polyangiitis (EGPA)
ItalyStudy of tezepelumab in patients with progressive pulmonary fibrosis and increased eosinophil levels in blood
GermanyStudy on Tezepelumab for Reducing Steroid Use in Adults with Steroid-Dependent Asthma
CzechiaTell us about your condition – we search every trial in Europe and connect you with the right site.
